Jim Simons’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.32M | Buy |
+29,000
| New | +$2.39M | ﹤0.01% | 1823 |
|
|
2025
Q3 | – | Sell |
-1,040,386
| Closed | -$81.4M | – | 3612 |
|
|
2025
Q2 | $81.4M | Buy |
1,040,386
+33,786
| +3% | +$2.52M | 0.11% | 199 |
|
|
2025
Q1 | $73M | Buy |
1,006,600
+354,107
| +54% | +$25.3M | 0.11% | 217 |
|
|
2024
Q4 | $48.3M | Sell |
652,493
-569,207
| -47% | -$39.8M | 0.07% | 336 |
|
|
2024
Q3 | $80.6M | Buy |
+1,221,700
| New | +$88.8M | 0.12% | 195 |
|
|
2023
Q4 | – | Sell |
-497,000
| Closed | -$34.4M | – | 3824 |
|
|
2023
Q3 | $34.4M | Buy |
+497,000
| New | +$39.9M | 0.06% | 375 |
|
|
2023
Q2 | – | Sell |
-452,204
| Closed | -$37.4M | – | 4023 |
|
|
2023
Q1 | $37.4M | Sell |
452,204
-784,696
| -63% | -$61.7M | 0.05% | 432 |
|
|
2022
Q4 | $92.3M | Buy |
1,236,900
+1,039,800
| +528% | +$80.1M | 0.13% | 168 |
|
|
2022
Q3 | $16.3M | Buy |
+197,100
| New | +$19M | 0.02% | 772 |
|
|
2022
Q1 | – | Sell |
-5,800
| Closed | -$751K | – | 4168 |
|
|
2021
Q4 | $751K | Sell |
5,800
-208,600
| -97% | -$24.3M | ﹤0.01% | 2856 |
|
|
2021
Q3 | $24.3M | Buy |
214,400
+206,300
| +2,547% | +$23.5M | 0.03% | 589 |
|
|
2021
Q2 | $839K | Sell |
8,100
-299,900
| -97% | -$28.3M | ﹤0.01% | 2756 |
|
|
2021
Q1 | $25.8M | Buy |
+308,000
| New | +$26M | 0.03% | 639 |
|
|
2020
Q4 | – | Sell |
-37,100
| Closed | -$2.96M | – | 3471 |
|
|
2020
Q3 | $2.96M | Sell |
37,100
-848,300
| -96% | -$66.2M | ﹤0.01% | 1884 |
|
|
2020
Q2 | $61.2M | Sell |
885,400
-328,700
| -27% | -$23.4M | 0.05% | 373 |
|
|
2020
Q1 | $76.3M | Buy |
1,214,100
+796,410
| +191% | +$57.4M | 0.07% | 275 |
|
|
2019
Q4 | $32.5M | Buy |
+417,690
| New | +$32.6M | 0.03% | 734 |
|
|
2018
Q3 | – | Sell |
-1,483,500
| Closed | -$72M | – | 3391 |
|
|
2018
Q2 | $72M | Sell |
1,483,500
-1,537,200
| -51% | -$71.7M | 0.08% | 296 |
|
|
2018
Q1 | $140M | Sell |
3,020,700
-760,641
| -20% | -$33M | 0.15% | 130 |
|
|
2017
Q4 | $142M | Sell |
3,781,341
-2,820,876
| -43% | -$104M | 0.16% | 129 |
|
|
2017
Q3 | $241M | Buy |
6,602,217
+4,043,517
| +158% | +$154M | 0.28% | 50 |
|
|
2017
Q2 | $101M | Sell |
2,558,700
-220,200
| -8% | -$8.04M | 0.13% | 173 |
|
|
2017
Q1 | $87.1M | Buy |
2,778,900
+183,300
| +7% | +$5.74M | 0.12% | 187 |
|
|
2016
Q4 | $81.1M | Sell |
2,595,600
-1,833,618
| -41% | -$59.4M | 0.13% | 174 |
|
|
2016
Q3 | $178M | Sell |
4,429,218
-2,212,182
| -33% | -$83.3M | 0.31% | 38 |
|
|
2016
Q2 | $221M | Buy |
6,641,400
+1,644,000
| +33% | +$56.2M | 0.42% | 17 |
|
|
2016
Q1 | $147M | Buy |
4,997,400
+1,682,100
| +51% | +$46.4M | 0.28% | 46 |
|
|
2015
Q4 | $87.3M | Buy |
3,315,300
+1,147,428
| +53% | +$29.8M | 0.19% | 82 |
|
|
2015
Q3 | $51.4M | Buy |
2,167,872
+426,672
| +25% | +$10.3M | 0.12% | 160 |
|
|
2015
Q2 | $41.3M | Sell |
1,741,200
-2,269,200
| -57% | -$51.2M | 0.09% | 244 |
|
|
2015
Q1 | $95.2M | Buy |
4,010,400
+1,103,400
| +38% | +$24.8M | 0.2% | 83 |
|
|
2014
Q4 | $61.7M | Buy |
2,907,000
+2,781,600
| +2,218% | +$55.9M | 0.15% | 130 |
|
|
2014
Q3 | $2.13M | Buy |
125,400
+9,600
| +8% | +$152K | 0.01% | 1638 |
|
|
2014
Q2 | $1.66M | Buy |
+115,800
| New | +$1.57M | ﹤0.01% | 1823 |
|
|
2014
Q1 | – | Sell |
-1,132,800
| Closed | -$12.4M | – | 2890 |
|
|
2013
Q4 | $12.4M | Sell |
1,132,800
-558,600
| -33% | -$6.3M | 0.03% | 685 |
|
|
2013
Q3 | $19.6M | Buy |
1,691,400
+219,600
| +15% | +$2.57M | 0.05% | 482 |
|
|
2013
Q2 | $16.5M | Buy |
+1,471,800
| New | +$17.4M | 0.04% | 522 |
|
Other funds holding EW
VCM
VPM
Jim Simons's EW Position: Q1 2026 in Review
Jim Simons opened a new position in Edwards Lifesciences (EW) in Q1 2026: 29,000 shares worth $2.32M. The stake represents ﹤0.01% of the portfolio and ranks #1823 among its holdings. This is a return to the name: Jim Simons previously reported a position in EW as recently as Q2 2025.
Jim Simons first reported a position in EW in Q2 2013 and has held it in 37 quarters since. The position peaked at $241M in Q3 2017. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Jim Simons held 29,000 shares of Edwards Lifesciences worth $2.32M as of Q1 2026.
- Edwards Lifesciences was a new Jim Simons position in Q1 2026.
- Edwards Lifesciences made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1823 holding.
- Jim Simons first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 37 quarters since.
- Jim Simons's Edwards Lifesciences position peaked at $241M in Q3 2017.
- 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.